NCT04001413 2022-07-29Therapy for High-Risk HPV 16-Positive Oropharynx Cancer PatientsSidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 2 Withdrawn
NCT02163057 2021-01-22Study of HPV Specific Immunotherapy in Participants With HPV Associated Head and Neck Squamous Cell CarcinomaInovio PharmaceuticalsPhase 1/2 Completed22 enrolled 14 charts